Quantifying Time to Diagnosis of CKD in the United States
Kidney360 · 2026
DOI: 10.34067/kid.0000001056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, 2026. Verfasst von Adrian R Levy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Electronic Health Records, Delayed Diagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim.
Abstract (Originalsprache)
Key Points Many people with CKD are unaware of the condition. We estimated the time to CKD documentation after two eGFR measurements taken at least 90 days apart. Among many persons with early stage CKD, there are considerable delays in documenting the diagnosis in electronic health record-linked claims data.
Background
An estimated 14% of US adults have CKD with over 90% unaware of their condition. Health care professionals diagnose CKD after two abnormal laboratory test results taken at least 3 months apart. Although there is evidence that delays from CKD onset to documentation are common, these delays remain unquantified. The objective of this study was to quantify the time from laboratory-based evidence of CKD to the documentation of CKD using International Classification of Diseases codes.
Methods
A retrospective longitudinal cohort study was conducted using 2009–2020 Optum Market Clarity data. Adults aged 18 years and older were followed from the date of the second of two eGFRs
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
- Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut.
- Panalgo, Boston, Massachusetts.
- University of Tennessee Health Science Center, Nashville, Tennessee.
ORCID-Profile: Adrian R Levy, Bonnie M K Donato, Ling Zhang
Förderung
- Boehringer Ingelheim
Zitieren
APA
Levy, A. R., Chatterjee, S., Stackland, S., Donato, B. M. K., Zhang, L., & Kovesdy, C. P. (2026). Quantifying Time to Diagnosis of CKD in the United States. Kidney360. https://doi.org/10.34067/kid.0000001056
Vancouver
Levy AR, Chatterjee S, Stackland S, Donato BMK, Zhang L, Kovesdy CP. Quantifying Time to Diagnosis of CKD in the United States. Kidney360. 2026. doi:10.34067/kid.0000001056
BibTeX
@article{Levy2026,
author = {Levy, Adrian R and Chatterjee, Satabdi and Stackland, Sydnie and Donato, Bonnie M K and Zhang, Ling and Kovesdy, Csaba P},
title = {Quantifying Time to Diagnosis of CKD in the United States},
journal = {Kidney360},
year = {2026},
doi = {10.34067/kid.0000001056}
}
EUVIMED